Tags:BuildingCommerceDevelopmentDrugHuman
We are passionate about creating small molecule medications by building on our in-depth understanding of pathologic pathways with a single goal in mind: improving the lives of all those who are affected by severe diseases.
Total raised: $19.409862M
Founded date: 1997

Investors 1

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
04.01.2012-$19.409862...-tvm-lifesc...

Mentions in press and media 3

DateTitleDescriptionCategoryAuthorSource
15.04.2019Probiodrug...Probiodrug wirbt EUR 8,2 Mio m...--bmp.com/de...
04.01.2012Probiodrug...HALLE/SAALE, Germany, Jan. 4 2...--tvm-lifesc...
02.11.2009Germany, P...Probiodrug AG, a Halle (Saale)...Germany v...-finsmes.co...